Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study.

Autor: Broeren, M. A. C.1,2, Schmitz, E. M. H.1,2,3,4, Scharnhorst, V.2,3,4, Brunsveld, L.2,4, Boekema, P. J.5, Straathof, J. W. A.5, van Renswouw, D. C.6, van de Poll, M. E. C.7, Derijks, L. J. J.7
Zdroj: Alimentary Pharmacology & Therapeutics. Feb2018, Vol. 47 Issue 3, p356-363. 8p. 2 Charts, 4 Graphs.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje